David Roman
Stock Analyst at Goldman Sachs
(3.33)
# 2,431
Out of 4,634 analysts
244
Total ratings
51.7%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $27.78 | -24.41% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $16.40 | +15.85% | 7 | Jul 15, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $71 → $57 | $50.46 | +12.96% | 11 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $21 → $16 | $22.81 | -29.86% | 7 | Jul 14, 2026 | |
| BLCO Bausch + Lomb | Maintained: Hold | $19 → $21 | $16.83 | +24.78% | 4 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $12.73 | +143.52% | 2 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $95 → $98 | $92.03 | +6.49% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $393.38 | +41.85% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Maintained: Buy | $26 → $25 | $24.99 | +0.04% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Maintained: Hold | $84 → $83 | $89.41 | -7.17% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $24 | $19.50 | +23.08% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $113 | $108.62 | +4.03% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $89 → $88 | $106.79 | -17.60% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $73 → $61 | $76.32 | -20.07% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $237 → $205 | $142.85 | +43.51% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $8 | $7.08 | +12.99% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $181.42 | -15.67% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $87.65 | -8.73% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $25.63 | -6.36% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $20.75 | -3.61% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $72 | $76.47 | -5.85% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $50 | $33.81 | +47.89% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $54 → $66 | $85.21 | -22.54% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $13.73 | +16.53% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $357 → $361 | $345.81 | +4.39% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $147 | $124.78 | +17.81% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $72.94 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $179.63 | -7.03% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $28.35 | -40.04% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $93 → $88 | $97.78 | -10.00% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $86.61 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $86.15 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $103 | $108.02 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $44 → $15 | $9.65 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $27.78
Upside: -24.41%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $16.40
Upside: +15.85%
Boston Scientific
Jul 14, 2026
Maintained: Buy
Price Target: $71 → $57
Current: $50.46
Upside: +12.96%
Tandem Diabetes Care
Jul 14, 2026
Maintained: Hold
Price Target: $21 → $16
Current: $22.81
Upside: -29.86%
Bausch + Lomb
Jul 14, 2026
Maintained: Hold
Price Target: $19 → $21
Current: $16.83
Upside: +24.78%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $12.73
Upside: +143.52%
Edwards Lifesciences
Jun 15, 2026
Maintained: Buy
Price Target: $95 → $98
Current: $92.03
Upside: +6.49%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $393.38
Upside: +41.85%
Omada Health
Jun 10, 2026
Maintained: Buy
Price Target: $26 → $25
Current: $24.99
Upside: +0.04%
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $84 → $83
Current: $89.41
Upside: -7.17%
Jun 3, 2026
Maintained: Buy
Price Target: $14 → $24
Current: $19.50
Upside: +23.08%
May 31, 2026
Maintained: Buy
Price Target: $121 → $113
Current: $108.62
Upside: +4.03%
May 29, 2026
Maintained: Sell
Price Target: $89 → $88
Current: $106.79
Upside: -17.60%
May 27, 2026
Maintained: Sell
Price Target: $73 → $61
Current: $76.32
Upside: -20.07%
May 27, 2026
Maintained: Buy
Price Target: $237 → $205
Current: $142.85
Upside: +43.51%
May 27, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $7.08
Upside: +12.99%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $181.42
Upside: -15.67%
May 15, 2026
Maintained: Buy
Price Target: $80
Current: $87.65
Upside: -8.73%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $25.63
Upside: -6.36%
May 13, 2026
Maintained: Buy
Price Target: $20
Current: $20.75
Upside: -3.61%
May 6, 2026
Maintained: Hold
Price Target: $73 → $72
Current: $76.47
Upside: -5.85%
May 6, 2026
Maintained: Buy
Price Target: $54 → $50
Current: $33.81
Upside: +47.89%
May 5, 2026
Maintained: Sell
Price Target: $54 → $66
Current: $85.21
Upside: -22.54%
May 5, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $13.73
Upside: +16.53%
May 1, 2026
Maintained: Hold
Price Target: $357 → $361
Current: $345.81
Upside: +4.39%
Apr 30, 2026
Maintained: Hold
Price Target: $147
Current: $124.78
Upside: +17.81%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.94
Upside: -
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $179.63
Upside: -7.03%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $28.35
Upside: -40.04%
Feb 10, 2026
Maintained: Sell
Price Target: $93 → $88
Current: $97.78
Upside: -10.00%
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $86.61
Upside: n/a
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $86.15
Upside: n/a
Nov 15, 2013
Maintained: Sell
Price Target: $103
Current: $108.02
Upside: n/a
Aug 30, 2012
Maintained: Hold
Price Target: $44 → $15
Current: $9.65
Upside: n/a